The Perception of Physicians on Gender-Specific Differences in the Diagnosis of COPD: Results from a Questionnaire-Based Survey

Overview of attention for article published in International Journal of Chronic Obstructive Pulmonary Disease, April 2021

Altmetric Badge

About this Attention Score

In the top 5% of all research outputs scored by Altmetric
One of the highest-scoring outputs from this source (#9 of 2,578)
High Attention Score compared to outputs of the same age (97th percentile)
High Attention Score compared to outputs of the same age and source (98th percentile)

Mentioned by

news: 18 news outlets

Citations

dimensions_citation: 3 Dimensions

Readers on

mendeley: 24 Mendeley

Summary News Dimensions citations

So far, Altmetric has seen 18 news stories from 18 outlets.

EpiEndo Pharmaceuticals Announces Launch of First-in-Human Clinical Trial of a Non-Antibiotic Macrolide for the Treatment of Chronic Inflammatory Airway Diseases

Biospace, 13 Apr 2021

April 13, 2021 06:00 UTC First-in-Human Clinical Trial of EpiEndo’s Lead Compound, EP395, for Chronic Inflammatory Airway…

EpiEndo Pharmaceuticals Announces Launch of First-in-Human Clinical Trial of a Non-Antibiotic Macrolide for the Treatment of Chronic Inflammatory Airway Diseases

Spoke, 13 Apr 2021

EpiEndo Pharmaceuticals Announces Launch of First-in-Human Clinical Trial of a Non-Antibiotic Macrolide for the Treatment of…

News story from Finanz Nachrichten on Tuesday 13 April 2021

Finanz Nachrichten, 13 Apr 2021

EpiEndo Pharmaceuticals Announces Launch of First-in-Human Clinical Trial of a Non-Antibiotic Macrolide for the Treatment of Chronic Inflammatory Airway Diseases

VB Profiles, 13 Apr 2021

First-in-Human Clinical Trial of EpiEndo’s Lead Compound, EP395, for Chronic Inflammatory Airway Diseases Commences at the…

EpiEndo Pharmaceuticals Announces Launch of First-in-Human Clinical Trial of a Non-Antibiotic Macrolide for the Treatment of Chronic Inflammatory Airway Diseases

Digital Journal, 13 Apr 2021

REYKJAVIK, Iceland--(Business Wire)-- ( www.epiendo.com ) a clinical-stage biopharmaceutical company developing novel non-antibio…

EpiEndo Pharmaceuticals : Announces Launch of First-in-Human Clinical Trial of a Non-Antibiotic Macrolide for the Treatment of Chronic Inflammatory Airway Diseases

MarketScreener, 13 Apr 2021

EpiEndo Pharmaceuticals (), a clinical-stage biopharmaceutical company developing novel non-antibiotic macrolide therapeutics…

EpiEndo Pharmaceuticals Announces Launch of First-in-Human Clinical Trial of a Non-Antibiotic Macrolide for the Treatment of Chronic Inflammatory Airway Diseases

Bakersfield, 13 Apr 2021

- EpiEndo Pharmaceuticals ( www.epiendo.com ), a clinical-stage biopharmaceutical company developing novel non-antibiotic…

EpiEndo Pharmaceuticals Announces Launch of First-in-Human Clinical Trial of a Non-Antibiotic Macrolide for the Treatment of Chronic Inflammatory Airway Diseases

Daily American, 13 Apr 2021

- EpiEndo Pharmaceuticals ( www.epiendo.com ), a clinical-stage biopharmaceutical company developing novel non-antibiotic…

EpiEndo Pharmaceuticals Announces Launch of First-in-Human Clinical Trial of a Non-Antibiotic Macrolide for the Treatment of Chronic Inflammatory Airway Diseases

Rome News Tribune, 13 Apr 2021

- EpiEndo Pharmaceuticals ( www.epiendo.com ), a clinical-stage biopharmaceutical company developing novel non-antibiotic…

EpiEndo Pharmaceuticals Announces Launch of First-in-Human Clinical Trial of a Non-Antibiotic Macrolide for the Treatment of Chronic Inflammatory Airway Diseases

OA Online, 13 Apr 2021

- EpiEndo Pharmaceuticals ( www.epiendo.com ), a clinical-stage biopharmaceutical company developing novel non-antibiotic…

EpiEndo Pharmaceuticals Announces Launch of First-in-Human Clinical Trial of a Non-Antibiotic Macrolide for the Treatment of Chronic Inflammatory Airway Diseases

The Daily Times, 13 Apr 2021

- EpiEndo Pharmaceuticals ( www.epiendo.com ), a clinical-stage biopharmaceutical company developing novel non-antibiotic…

EpiEndo Pharmaceuticals Announces Launch of First-in-Human Clinical Trial of a Non-Antibiotic Macrolide for the Treatment of Chronic Inflammatory Airway Diseases

Watertown Public Opinion, 13 Apr 2021

- EpiEndo Pharmaceuticals ( www.epiendo.com ), a clinical-stage biopharmaceutical company developing novel non-antibiotic…

EpiEndo Pharmaceuticals Announces Launch of First-in-Human Clinical Trial of a Non-Antibiotic Macrolide for the Treatment of Chronic Inflammatory Airway Diseases

Cadillac News, 13 Apr 2021

- EpiEndo Pharmaceuticals ( www.epiendo.com ), a clinical-stage biopharmaceutical company developing novel non-antibiotic…

EpiEndo Pharmaceuticals Announces Launch of First-in-Human Clinical Trial of a Non-Antibiotic Macrolide for the Treatment of Chronic Inflammatory Airway Diseases

Benzinga, 13 Apr 2021

First-in-Human Clinical Trial of EpiEndo's Lead Compound, EP395, for Chronic Inflammatory Airway Diseases Commences at the…

EpiEndo Pharmaceuticals Announces Launch of First-in-Human Clinical Trial of a Non-Antibiotic Macrolide for the Treatment of Chronic Inflammatory Airway Diseases

ANSA.it, 13 Apr 2021

EpiEndo Pharmaceuticals (www.epiendo.com), a clinical-stage biopharmaceutical company developing novel non-antibiotic macrolide…

EpiEndo Pharmaceuticals Announces Launch of First-in-Human Clinical Trial of a Non-Antibiotic Macrolide for the Treatment of Chronic Inflammatory Airway Diseases

Yahoo! Finance USA, 13 Apr 2021

First-in-Human Clinical Trial of EpiEndo’s Lead Compound, EP395, for Chronic Inflammatory Airway Diseases Commences at the…

EpiEndo Pharmaceuticals Announces Launch of First-in-Human Clinical Trial of a Non-Antibiotic Macrolide for the Treatment of Chronic Inflammatory Airway Diseases

Morning Star, 13 Apr 2021

First-in-Human Clinical Trial of EpiEndo’s Lead Compound, EP395, for Chronic Inflammatory Airway Diseases Commences at the…

EpiEndo Pharmaceuticals Announces Launch of First-in-Human Clinical Trial of a Non-Antibiotic Macrolide for the Treatment of Chronic Inflammatory Airway Diseases

Business Wire, 13 Apr 2021

First-in-Human Clinical Trial of EpiEndo’s Lead Compound, EP395, for Chronic Inflammatory Airway Diseases Commences at the…